The global ophthalmic surgical devices and therapeutics market is expected to reach a value of US$ 68898.4 Mn by the end of 2026, expanding at a significant CAGR of 5.8% during the forecast period. Increase in prevalence and incidence rates of eye-related disorders, high unmet needs in patients with ocular diseases, increased geriatric population, and raised awareness about eye diseases in developing countries are expected to boost the ophthalmic surgical devices and therapeutics market during the forecast period. Moreover, significant rise in incidence of eye-related diseases, especially in developed countries, is anticipated to drive the ophthalmic surgical devices and therapeutics market between 2018 and 2026. According to the Prevent Blindness Report, the number of people in the U.S. suffering from cataract is expected to increase from 24.4 million in 2010, to 30.5 million by 2020, and the number of people suffering from diabetic retinopathy in the U.S. is projected to rise from 7.7 million in 2010 to reach 9.2 million by 2020.
The global ophthalmic surgical devices and therapeutics market has been segmented based on product type, end-user, and region. In terms of product type, the global market has been classified into therapeutics, surgical devices, and vision care. The therapeutics segment dominates the ophthalmic surgical devices and therapeutics market, in terms of value. The therapeutics segment has been segmented further into anti-inflammatory drugs, anti-infective drugs, anti-glaucoma drugs, anti-allergy drugs, anti-VEGF agents, and others. The wide acceptance of therapeutics as the first line of treatment for any eye-related disorder is likely to drive the segment. The vision care segment is expected to expand at a significant CAGR during forecast period. This is primarily attributed to the increased prevalence of refractive errors among the population, including the young population. According to an article published by Journal of Current Ophthalmology, in 2018, astigmatism is a highly common refractive error among children and adults, followed by hyperopia and myopia. Myopia and astigmatism are highly prevalent among adults in Southeast Asia, and a considerably high prevalence of hyperopia is found among the children and adults in the U.S. population.
In terms of end-user, the ophthalmic surgical devices and therapeutics market has been segregated into hospitals, ophthalmic clinics, and ambulatory surgery centers. The hospitals segment held a major share of the market in 2017, followed by ophthalmic clinics. The hospitals segment is expected to maintain its market share during the forecast period due to increased preferences for hospitals for any eye-related diseases. The ophthalmic clinics segment is projected to expand at a considerable CAGR during the forecast period. The high growth rate of this segment is due to its convenience, improved security, one-stop service offered by clinics, improved infrastructure, and increased preferences to ophthalmic clinics for IVT (Intravitreal) administration.
In terms of region, the ophthalmic surgical devices and therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the ophthalmic surgical devices and therapeutics market, owing to the high awareness about eye-related disorders in the U.S., increased prevalence of eye diseases, technological advancements, and healthcare spending in the region. The market in Asia Pacific is anticipated expand at a considerably high CAGR during the forecast period, owing to the increased awareness regarding ocular diseases in developing countries, such as India, and governments’ initiatives for prevention of blindness in the region.
Major players operating in the ophthalmic surgical devices and therapeutics market include Allergan Plc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Bausch Health Companies Inc., Regeneron Pharmaceuticals, Inc., Santen Pharmaceutical Co., Ltd., Carl Zeiss Meditec AG, HOYA Corporation, and Bayer AG. Key players are expanding their product portfolios through mergers & acquisitions and partnerships & collaborations with leading pharmaceutical companies, which is expected to increase product availability, and thereby boost the market.
An eye is one of the fragile organs of human body, and thus needs to be given extensive care during, before, and after any type of surgery. This helps in preventing or minimizing the further damage to eye. Over the period of past few years, there is extensive growth in the number of people across the world that are living with eye-related health issues. For instance, the Prevent Blindness Report highlights that there is remarkable growth in the number of the U.S. populace dealing with the issue of cataract. The report notes that this patient number was about 24.4 Mn in 2010, and is likely to grow and touch the value of approximately 30.5 Mn by 2020. Moreover, the number of diabetic retinopathy patients in the U.S. are expected to escalate from about 7.7 Mn in 2010 and touch the figure of 9.2 Mn by 2020. Thus, notable growth in the cases of eye-related disorders is opening promising sales avenues for companies working in the ophthalmic surgical devices and therapeutics (eye care) market.
Over the period of past few years, there is remarkable growth in awareness among major worldwide population, specifically among people from various developing countries, regarding eye disorders. This scenario has resulted into increased number of various ophthalmic surgeries, and thereby boosting the demand for different ophthalmic surgical devices and therapeutics.
Major players working in the global ophthalmic surgical devices and therapeutics (eye care) market are engaging into diverse strategic collaborations and joint ventures with prominent pharmaceutical companies across the globe. Apart from this, several enterprises are increasing interest in merger and acquisition activities. These moves are helping enterprises expand their businesses across new geographical regions. This aside, these companies are more focused on research and development activities. On the back of all these activities, the ophthalmic surgical devices and therapeutics (eye care) market is expected to grow at prodigious pace in the forthcoming years.
The global ophthalmic surgical devices and therapeutics market has been segmented as below:
|
Product Type
|
|
|
End-user
|
|
|
Region |
|
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Ophthalmic Surgical Devices and Therapeutics Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Pipeline Analysis
5.2. Technological Advancements
5.3. Snapshot: Ocular Diseases Leading to Visual Impairment & Analysis of Global Causes of Blindness (%)
6. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
6.3.1. Therapeutics
6.3.1.1. Anti-inflammatory Drugs
6.3.1.1.1. NSAIDs
6.3.1.1.2. Steroids
6.3.1.2. Anti-infective Drugs
6.3.1.2.1. Anti-fungal Drugs
6.3.1.2.2. Anti-bacterial Drugs
6.3.1.2.3. Others
6.3.1.3. Anti-glaucoma Drugs
6.3.1.3.1. Alpha Agonist
6.3.1.3.2. Beta Blockers
6.3.1.3.3. Prostaglandin Analogs
6.3.1.3.4. Combined Medication
6.3.1.3.5. Others
6.3.1.4. Anti-allergy Drugs
6.3.1.5. Anti-VEGF Agents
6.3.1.6. Others
6.3.2. Surgical Devices
6.3.2.1. Cataract Surgery Devices
6.3.2.1.1. Intraocular lens (IOL)
6.3.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
6.3.2.1.3. Others
6.3.2.2. Glaucoma Surgery Devices
6.3.2.3. Refractive Surgery Devices
6.3.2.4. Vitreoretinal Surgery Devices
6.3.3. Vision Care
6.3.3.1. Contact Lenses
6.3.3.2. Spectacle Lenses
6.3.3.3. Accessories
6.4. Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type
7. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
7.3.1. Hospitals
7.3.2. Ophthalmic Clinics
7.3.3. Ambulatory Surgery Centers
7.4. Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user
8. Global Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Country/Region
9. North America Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
9.2.1. Therapeutics
9.2.1.1. Anti-inflammatory Drugs
9.2.1.1.1. NSAIDs
9.2.1.1.2. Steroids
9.2.1.2. Anti-infective Drugs
9.2.1.2.1. Anti-fungal Drugs
9.2.1.2.2. Anti-bacterial Drugs
9.2.1.2.3. Others
9.2.1.3. Anti-glaucoma Drugs
9.2.1.3.1. Alpha Agonist
9.2.1.3.2. Beta Blockers
9.2.1.3.3. Prostaglandin Analogs
9.2.1.3.4. Combined Medication
9.2.1.3.5. Others
9.2.1.4. Anti-allergy Drugs
9.2.1.5. Anti-VEGF Agents
9.2.1.6. Others
9.2.2. Surgical Devices
9.2.2.1. Cataract Surgery Devices
9.2.2.1.1. Intraocular lens (IOL)
9.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
9.2.2.1.3. Others
9.2.2.2. Glaucoma Surgery Devices
9.2.2.3. Refractive Surgery Devices
9.2.2.4. Vitreoretinal Surgery Devices
9.2.3. Vision Care
9.2.3.1. Contact Lenses
9.2.3.2. Spectacle Lenses
9.2.3.3. Accessories
9.3. North America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
9.3.1. Hospitals
9.3.2. Ophthalmic Clinics
9.3.3. Ambulatory Surgery Centers
9.4. North America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country, 2016–2026
9.4.1. US
9.4.2. Canada
9.5. North America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Europe Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
10.2.1. Therapeutics
10.2.1.1. Anti-inflammatory Drugs
10.2.1.1.1. NSAIDs
10.2.1.1.2. Steroids
10.2.1.2. Anti-infective Drugs
10.2.1.2.1. Anti-fungal Drugs
10.2.1.2.2. Anti-bacterial Drugs
10.2.1.2.3. Others
10.2.1.3. Anti-glaucoma Drugs
10.2.1.3.1. Alpha Agonist
10.2.1.3.2. Beta Blockers
10.2.1.3.3. Prostaglandin Analogs
10.2.1.3.4. Combined Medication
10.2.1.3.5. Others
10.2.1.4. Anti-allergy Drugs
10.2.1.5. Anti-VEGF Agents
10.2.1.6. Others
10.2.2. Surgical Devices
10.2.2.1. Cataract Surgery Devices
10.2.2.1.1. Intraocular lens (IOL)
10.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
10.2.2.1.3. Others
10.2.2.2. Glaucoma Surgery Devices
10.2.2.3. Refractive Surgery Devices
10.2.2.4. Vitreoretinal Surgery Devices
10.2.3. Vision Care
10.2.3.1. Contact Lenses
10.2.3.2. Spectacle Lenses
10.2.3.3. Accessories
10.3. Europe Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
10.3.1. Hospitals
10.3.2. Ophthalmic Clinics
10.3.3. Ambulatory Surgery Centers
10.4. Europe Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016–2026
10.4.1. Germany
10.4.2. France
10.4.3. U.K.
10.4.4. Italy
10.4.5. Spain
10.4.6. Rest of Europe
10.5. Europe Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
10.5.1. By Product Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
11.2.1. Therapeutics
11.2.1.1. Anti-inflammatory Drugs
11.2.1.1.1. NSAIDs
11.2.1.1.2. Steroids
11.2.1.2. Anti-infective Drugs
11.2.1.2.1. Anti-fungal Drugs
11.2.1.2.2. Anti-bacterial Drugs
11.2.1.2.3. Others
11.2.1.3. Anti-glaucoma Drugs
11.2.1.3.1. Alpha Agonist
11.2.1.3.2. Beta Blockers
11.2.1.3.3. Prostaglandin Analogs
11.2.1.3.4. Combined Medication
11.2.1.3.5. Others
11.2.1.4. Anti-allergy Drugs
11.2.1.5. Anti-VEGF Agents
11.2.1.6. Others
11.2.2. Surgical Devices
11.2.2.1. Cataract Surgery Devices
11.2.2.1.1. Intraocular lens (IOL)
11.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
11.2.2.1.3. Others
11.2.2.2. Glaucoma Surgery Devices
11.2.2.3. Refractive Surgery Devices
11.2.2.4. Vitreoretinal Surgery Devices
11.2.3. Vision Care
11.2.3.1. Contact Lenses
11.2.3.2. Spectacle Lenses
11.2.3.3. Accessories
11.3. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
11.3.1. Hospitals
11.3.2. Ophthalmic Clinics
11.3.3. Ambulatory Surgery Centers
11.4. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016–2026
11.4.1. Japan
11.4.2. China
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
11.5.1. By Product Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
12.2.1. Therapeutics
12.2.1.1. Anti-inflammatory Drugs
12.2.1.1.1. NSAIDs
12.2.1.1.2. Steroids
12.2.1.2. Anti-infective Drugs
12.2.1.2.1. Anti-fungal Drugs
12.2.1.2.2. Anti-bacterial Drugs
12.2.1.2.3. Others
12.2.1.3. Anti-glaucoma Drugs
12.2.1.3.1. Alpha Agonist
12.2.1.3.2. Beta Blockers
12.2.1.3.3. Prostaglandin Analogs
12.2.1.3.4. Combined Medication
12.2.1.3.5. Others
12.2.1.4. Anti-allergy Drugs
12.2.1.5. Anti-VEGF Agents
12.2.1.6. Others
12.2.2. Surgical Devices
12.2.2.1. Cataract Surgery Devices
12.2.2.1.1. Intraocular lens (IOL)
12.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
12.2.2.1.3. Others
12.2.2.2. Glaucoma Surgery Devices
12.2.2.3. Refractive Surgery Devices
12.2.2.4. Vitreoretinal Surgery Devices
12.2.3. Vision Care
12.2.3.1. Contact Lenses
12.2.3.2. Spectacle Lenses
12.2.3.3. Accessories
12.3. Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
12.3.1. Hospitals
12.3.2. Ophthalmic Clinics
12.3.3. Ambulatory Surgery Centers
12.4. Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016–2026
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Latin America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
12.5.1. By Product Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Product Type, 2016–2026
13.2.1. Therapeutics
13.2.1.1. Anti-inflammatory Drugs
13.2.1.1.1. NSAIDs
13.2.1.1.2. Steroids
13.2.1.2. Anti-infective Drugs
13.2.1.2.1. Anti-fungal Drugs
13.2.1.2.2. Anti-bacterial Drugs
13.2.1.2.3. Others
13.2.1.3. Anti-glaucoma Drugs
13.2.1.3.1. Alpha Agonist
13.2.1.3.2. Beta Blockers
13.2.1.3.3. Prostaglandin Analogs
13.2.1.3.4. Combined Medication
13.2.1.3.5. Others
13.2.1.4. Anti-allergy Drugs
13.2.1.5. Anti-VEGF Agents
13.2.1.6. Others
13.2.2. Surgical Devices
13.2.2.1. Cataract Surgery Devices
13.2.2.1.1. Intraocular lens (IOL)
13.2.2.1.2. Ophthalmic Viscoelastic Devices (OVDs)
13.2.2.1.3. Others
13.2.2.2. Glaucoma Surgery Devices
13.2.2.3. Refractive Surgery Devices
13.2.2.4. Vitreoretinal Surgery Devices
13.2.3. Vision Care
13.2.3.1. Contact Lenses
13.2.3.2. Spectacle Lenses
13.2.3.3. Accessories
13.3. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by End-user, 2016–2026
13.3.1. Hospitals
13.3.2. Ophthalmic Clinics
13.3.3. Ambulatory Surgery Centers
13.4. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Forecast, by Country/Sub-region, 2016–2026
13.4.1. GCC Countries
13.4.2. Israel
13.4.3. South Africa
13.4.4. Rest of MEA
13.5. Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Attractiveness Analysis
13.5.1. By Product Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (By Tier and Size of companies)
14.2. Company Profiles
14.2.1. Allergan plc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.2. Novartis AG
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.3. Johnson & Johnson Vision Care, Inc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.4. Bayer AG
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.5. F. Hoffmann-La Roche Ltd.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.6. Bausch Health Companies Inc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.7. Regeneron Pharmaceuticals, Inc.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.8. Santen Pharmaceutical Co., Ltd.
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.2.9. HOYA Corporation
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
14.5.10. Carl Zeiss Meditec AG
14.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.2.1.2. Product Portfolio
14.2.1.3. SWOT Analysis
14.2.1.4. Financial Overview
14.2.1.5. Strategic Overview
List of Tables
Table 01: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 02: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 03: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016–2026
Table 04: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016–2026
Table 05: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, Anti-glaucoma Drugs, 2016–2026
Table 06: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 07: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 08: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 09: Global Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 10: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Region, 2016–2026
Table 11: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country, 2016–2026
Table 12: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 13: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 14: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-inflammatory Drugs, 2016–2026
Table 15: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-infective Drugs, 2016–2026
Table 16: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics- Anti-glaucoma Drugs, 2016–2026
Table 17: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 18: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 19: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 20: North America Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 21: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2016–2026
Table 22: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 23: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 24: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-inflammatory Drugs, 2016–2026
Table 25: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics - Anti-infective Drugs, 2016–2026
Table 26: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics- Anti-glaucoma Drugs, 2016–2026
Table 27: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 28: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 29: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 30: Europe Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 31: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 32: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 33: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 34: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016–2026
Table 35: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016–2026
Table 36: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-glaucoma Drugs, 2016–2026
Table 37: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 38: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 39: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 40: Asia Pacific Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 41: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 42: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 43: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 44: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016–2026
Table 45: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016–2026
Table 46: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-glaucoma Drugs, 2016–2026
Table 47: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 48: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 49: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 50: Latin America Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
Table 51: Middle East & Africa Allergy-relieving Eye Drops Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 52: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Product Type, 2016–2026
Table 53: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Therapeutics, 2016–2026
Table 54: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-inflammatory Drugs, 2016–2026
Table 55: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-infective Drugs, 2016–2026
Table 56: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Anti-glaucoma Drugs, 2016–2026
Table 57: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Surgical Devices, 2016–2026
Table 58: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Cataract Surgery Devices, 2016–2026
Table 59: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, by Vision Care, 2016–2026
Table 60: Middle East & Africa Ophthalmology Surgical Devices Market Value (US$ Mn) Forecast, by End-user, 2016–2026
List of Figures
Figure 01: Global Ophthalmic Surgical Devices and Therapeutics Market Snapshot
Figure 02: Global Ophthalmic Surgical Devices and Therapeutics Market, by Product Type
Figure 03: Global Ophthalmic Surgical Devices and Therapeutics Market Snapshot
Figure 04: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type
Figure 05: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user
Figure 06: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast, 2016–2026
Figure 07: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type (2017)
Figure 08: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user (2017)
Figure 09: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Region (2017)
Figure 10: Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type, 2018–2026
Figure 11: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
Figure 12: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection (%), by Therapeutics, 2016–2026
Figure 13: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection (%), by Surgical Devices, 2016–2026
Figure 14: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection (%), by Vision Care, 2016–2026
Figure 15: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
Figure 16: Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018–2026
Figure 18: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection (%), by Ophthalmic Clinics, 2016–2026
Figure 17: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection (%), by Hospitals, 2016–2026
Figure 19: Global Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) and Y-o-Y Growth Projection Ambulatory Surgery Centers, 2016–2026
Figure 20: Global Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Region, for 2017 and 2026
Figure 21: Global Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Region, 2018–2026
Figure 22: North America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 23: North America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Country, 2018–2026
Figure 24: North America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Country, 2017 and 2026
Figure 25: North America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type, 2016–2026
Figure 26: North America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
Figure 27: North America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
Figure 28: North America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018–2026
Figure 29: Europe Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 30: Europe Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Country/Sub-Region, 2018–2026
Figure 31: Europe Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Country/Sub-Region, 2017 and 2026
Figure 32: Europe Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type, 2016–2026
Figure 33: Europe Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
Figure 34: Europe Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
Figure 35: Europe Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018–2026
Figure 36: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 37: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 38: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Country/Sub-region, for 2017 and 2026
Figure 39: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type, 2016–2026
Figure 40: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
Figure 41: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
Figure 42: Asia Pacific Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018–2026
Figure 43: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 44: Latin America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Country/Sub-region, 2018–2026
Figure 45: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Country/Sub-region, 2017 and 2026
Figure 46: Latin America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by Product Type, 2016–2026
Figure 47: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
Figure 48: Latin America Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
Figure 49: Latin America Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018–2026
Figure 50: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2016–2026
Figure 51: Middle East & Africa Allergy-relieving Eye Drops Market Attractiveness, by Country/Sub-Region, 2018–2026
Figure 52: Middle East & Africa Allergy-relieving Eye Drops Market Value Share, by Country/Sub-Region, 2017 and 2026
Figure 53: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, By Product Type, 2016–2026
Figure 54: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Share, by Product Type, 2017 and 2026
Figure 55: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Value Share, by End-user, for 2017 and 2026
Figure 56: Middle East & Africa Ophthalmic Surgical Devices and Therapeutics Market Attractiveness, by End-user, 2018–2026
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Ophthalmic Surgical Devices and Therapeutics (Eye Care) Market
